Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EMA Rejects Bevacizumab Drug For Use In Wet AMD

European Commission Approves COVID-19 Products Ronapreve & Regkirona

12 Nov 2021

• By Ian Schofield

Macular degeneration - loss of the central field of vision. — Macular degeneration can seriously impair vision • Source: Alamy

Related Content

EMA Prepares To Deliver Verdict On Bevacizumab In Wet AMD

08 Nov 2021

EMA Greenlights Ronapreve & Regkirona For COVID-19 In EU

11 Nov 2021

Related Companies

Roche Holding AG

Additional Topics

Europe Drug Review Regulation Ophthalmic BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.